Stryker stock falls on slower peripheral vascular, hip sales
Published . Updated .
CFO Preston Wells said at a healthcare conference that the company is still working through supply issues in its peripheral vascular business and had fewer hip sales than expected so far this quarter.
Directly affected
- SYK Stryker
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- UNH UnitedHealth
A large health insurer
- JNJ Johnson & Johnson
A large health-care company
- LLY Eli Lilly
A large drug maker
- PFE Pfizer
A large drug maker
- BAMG BROOKSTONE GROWTH STOCK ETF
GA selected BAMG as a RELATED security because its canonical security name directly matches this event's themes: stock. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BAMV BROOKSTONE VALUE STOCK ETF
GA selected BAMV as a RELATED security because its canonical security name directly matches this event's themes: stock. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
CFO Preston Wells said at a healthcare conference that the company is still working through supply issues in its peripheral vascular business and had fewer hip sales than expected so far this quarter.
Source: MedTech Dive
Stryker (SYK) since “Stryker stock falls on slower peripheral vascular, hip sales,” compared with the market
Since the first closing price after “Stryker stock falls on slower peripheral vascular, hip sales,” Stryker (SYK) is +5.70%. The S&P 500 fund (SPY) is +0.77% over the same days, a +4.94% difference versus the market.
Disclosure records for Stryker (SYK) within two months of 12 Sep 2026
- Rohit Khanna sell Stryker (SYK) ($1,001 - $15,000). That is 13 days after publication, inside 30 days. The filing is listed beside the story “Stryker stock falls on slower peripheral vascular, hip sales.”
- Rohit Khanna sell Stryker (SYK) ($15,001 - $50,000). That is 1 days before publication, inside 30 days. The filing is listed beside the story “Stryker stock falls on slower peripheral vascular, hip sales.”
- Rohit Khanna buy Stryker (SYK) ($1,001 - $15,000). That is 8 days before publication, inside 30 days. The filing is listed beside the story “Stryker stock falls on slower peripheral vascular, hip sales.”
- Thomas H. Kean Jr sell Stryker (SYK) ($1,001 - $15,000). That is 52 days before publication, inside 60 days. The filing is listed beside the story “Stryker stock falls on slower peripheral vascular, hip sales.”
- Donald J Trump sell Stryker (SYK) ($15,001 - $50,000). That is 57 days before publication, inside 60 days. The filing is listed beside the story “Stryker stock falls on slower peripheral vascular, hip sales.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Stryker (SYK)
Companies mentioned with this story
- SYK Stryker
In “Stryker stock falls on slower peripheral vascular, hip sales,” Stryker (SYK) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names STRYKER CORPORATION in the headline; GA resolved that company to SYK
- BAMG Brookstone Growth Stock Etf
For “Stryker stock falls on slower peripheral vascular, hip sales,” Brookstone Growth Stock Etf (BAMG) is linked, with no stored direction, medium confidence. Reason on file: GA selected BAMG as a RELATED security because its canonical security name directly matches this event's themes: stock. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BAMV Brookstone Value Stock Etf
Brookstone Value Stock Etf (BAMV) is linked, with no stored direction, medium confidence in the 12 Sep 2026 story “Stryker stock falls on slower peripheral vascular, hip sales.” Reason on file: GA selected BAMV as a RELATED security because its canonical security name directly matches this event's themes: stock. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Stryker stock falls on slower peripheral vascular, hip sales” reaches Stryker (SYK)
Stryker (SYK) is the company in “Stryker stock falls on slower peripheral vascular, hip sales,” the 12 Sep 2026 this story story.
For Stryker (SYK), the reason on file says The reported development directly names STRYKER CORPORATION in the headline; GA resolved that company to SYK
Also listed, Brookstone Growth Stock Etf (BAMG): GA selected BAMG as a RELATED security because its canonical security name directly matches this event's themes: stock. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Stryker (SYK), and the dates in the story
BAMG traded between 43.54 and 45.76 across 11 sessions. The latest close on file is 45.02. BAMV traded between 36.14 and 38.33 across 18 sessions. The latest close on file is 36.79. SYK traded between 269.39 and 301.09 across 20 sessions. The latest close on file is 297.98.
A simple score for Stryker (SYK)
27 out of 100
“Stryker stock falls on slower peripheral vascular, hip sales” scores 27 out of 100. The score uses 1 sources, and 3 linked companies.